Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research (Q44121924)

30 November 2017

Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research (English)

1 reference

Duchenne muscular dystrophy

30 November 2017

1 reference

1

Francesco Muntoni

1 reference

30 November 2017

Ivan Fisher

2

1 reference

PubMed ID

12206811

30 November 2017

Jennifer E Morgan

series ordinal

3

1 reference

PubMed ID

12206811

30 November 2017

David Abraham

series ordinal

4

1 reference

30 November 2017

1 October 2002

1 reference

30 November 2017

Neuromuscular Disorders

1 reference

30 November 2017

12 Suppl 1

1 reference

30 November 2017

S162-5

1 reference

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

75th European Neuromuscular Centre International Workshop: 2nd workshop on the treatment of muscular dystrophy 10-12 December, 1999, Naarden, The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Long-term benefit from prednisone therapy in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Steroids in Duchenne muscular dystrophy; pilot study of a new low-dosage schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Remission of clinical signs in early duchenne muscular dystrophy on intermittent low-dosage prednisolone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Dexamethasone effects on myoblast proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Prednisolone enhances myogenesis and dystrophin-related protein in skeletal muscle cell cultures from mdx mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Prednisone can protect against exercise-induced muscle damage

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Glucocorticoids and immunosuppressants do not change the prevalence of necrosis and regeneration in mdx skeletal muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Modulation by prednisolone of calcium handling in skeletal muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

The effect of methylprednisolone on intracellular calcium of normal and dystrophic human skeletal muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Pre-clinical screening of drugs using the mdx mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

Identification of altered gene expression in skeletal muscles from Duchenne muscular dystrophy patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900101-3

7 January 2021

10.1016/S0960-8966(02)00101-3

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12206811